Detecting monogenic disorders in utero non-invasively based on fetal nucleated red blood cells highly-purified by multi-functional magnetic nanoparticles
Analytica Chimica Acta · 2025-03 · 1343 · 343690
DOI: 10.1016/j.aca.2025.343690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025-03. Verfasst von Lin Cheng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Hubei Clinical Research Center for Prenatal Diagnosis and Birt…. Hauptthemen laut MEDLINE: Magnetite Nanoparticles, Prenatal Diagnosis, Noninvasive Prenatal Testing, Genetic Diseases, Inborn. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Wuhan University.
Abstract (Originalsprache)
BACKGROUND: Fetal monogenic disorders cause gestation anomalies, birth defects or infant mortality. Implementing non-invasive prenatal testing (NIPT) of these diseases benefits timely intervention while avoids high risk of inducing maternal complications and fetal injuries. However, fetal materials used for current NIPT (e.g., blood-borne cell-free fetal DNA (cffDNA)) are inevitably interfered by tremendous maternal interference in peripheral blood, leading to difficulty of exactly analyzing fetal monogenic mutations. Fetal nucleated red blood cells (FNRBCs) in maternal peripheral blood possess the entire fetal genome, which is encapsulated inside the cells and is away from maternal interference. Therefore, FNRBCs are promising and superior for NIPT of fetal genetic disorders after they are highly purified from huge maternal blood cells and subsequently analyzed. RESULTS: We synthesized multi-functional magnetic nanoparticles (MMNs) by coating erythrocyte-leukocyte hybrid membrane on Fe3O4 magnetic nanoparticles and grafting specific antibody (anti-CD147) to highly purify FNRBCs from maternal peripheral blood. Fetal origin of all the isolated cells were confirmed by short tandem repeat (STR) to validate their sufficient purity for downstream analysis. Potential maternal factors that would influence FNRBC counts were evaluated based on clinical samples. Utilizing Sanger sequencing and droplet digital PCR (ddPCR), FNRBCs were analyzed to non-invasively assess the risk of five kinds of fetal monogenic disorders, which was challenging for current NIPT. SIGNIFICANCE: It is anticipated that this MMN-based strategy will create possibilities for overcoming limitations of NIPT when detecting fetal monogenic disorders nowadays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health, Wuhan, 430071, China.
- Department of Gynecology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430070, China.
- Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan, 430072, China.
- Hubei Key Laboratory of Environmental and Health Effects of Persistent Toxic Substances, School of Environment and Health, Jianghan University, Wuhan, 430056, China.
- Department of Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health, Wuhan, 430071, China; Genetics and Prenatal Diagnosis Center…
- Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health, Wuhan, 430071, China; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Förderung
- National Natural Science Foundation of China
- Wuhan University
Zitieren
APA
Cheng, L., Feng, C., Wu, K., Wang, Z., Zhu, W., Geng, T., Li, N., Kang, J., Duan, J., Li, J., Shao, Y., Yang, S., Peng, J., Cai, B., Ma, J., Zhao, X., & Zhang, Y. (2025). Detecting monogenic disorders in utero non-invasively based on fetal nucleated red blood cells highly-purified by multi-functional magnetic nanoparticles. Analytica Chimica Acta, 1343, 343690. https://doi.org/10.1016/j.aca.2025.343690
Vancouver
Cheng L, Feng C, Wu K, Wang Z, Zhu W, Geng T, et al. Detecting monogenic disorders in utero non-invasively based on fetal nucleated red blood cells highly-purified by multi-functional magnetic nanoparticles. Analytica Chimica Acta. 2025;1343:343690. doi:10.1016/j.aca.2025.343690
BibTeX
@article{Cheng2025,
author = {Cheng, Lin and Feng, Chun and Wu, Ke and Wang, Zixiang and Zhu, Wentao and Geng, Ting and Li, Naiqi and Kang, Jiawei and Duan, Jie and Li, Jin and Shao, Yuqi and Yang, Saisai and Peng, Jianhong and Cai, Bo and Ma, Jianhong and Zhao, Xingzhong and Zhang, Yuanzhen},
title = {Detecting monogenic disorders in utero non-invasively based on fetal nucleated red blood cells highly-purified by multi-functional magnetic nanoparticles},
journal = {Analytica Chimica Acta},
year = {2025},
volume = {1343},
pages = {343690},
doi = {10.1016/j.aca.2025.343690}
}
EUVIMED